Company intelligence / Profile preview

Phoenix Nest Inc.

Brooklyn, New York, United Statesthe-phoenix-nest.com ↗

Ownership: Private
Employees: ~50
Development stage: Phase 1

Overview

The company is developing treatments for Sanfilippo syndrome, an ultra-rare genetic disorder. They have received Small Business Innovation Research grants from NIH to facilitate research in academic labs and have licensed these programs. Currently, they have drugs in preclinical and discovery stages.

Therapeutic areas: Rare Diseases
Modalities: Recombinant polypeptideAAV-based gene therapyEnzyme
Industry: Biotech

Drug pipeline

4 assets

JLK-247

Preclinical

3 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with leading academics

Beyond the preview

Go deeper on Phoenix Nest Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phoenix Nest Inc..

Explore the full profile